Skip to main content
Clinical Trials/ISRCTN96672098
ISRCTN96672098
Completed
N/A

Telerehab II: a prospective randomised controlled trial that explores the effect on VO2 peak of coronary artery disease patients receiving telerehabilitation, with those receiving conventional cardiac rehabilitation

Heart Centre Hasselt vzw (Belgium)0 sites80 target enrollmentApril 17, 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Coronary artery disease
Sponsor
Heart Centre Hasselt vzw (Belgium)
Enrollment
80
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 17, 2013
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Heart Centre Hasselt vzw (Belgium)

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients (both male and female) that suffered an uncomplicated acute coronary syndrome (ACS) for which a percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) was performed
  • 2\. All included patients possessed a personal computer and internet connection
  • 3\. Their age did not exceed 80 years old

Exclusion Criteria

  • 1\. Patients more than 80 years old
  • 2\. Patients that have an Implantable Cardioverter Defibrillator (ICD) or pacemaker
  • 3\. Patients that suffered from severe arrhythmias
  • 4\. Patients that had persistent exertional ischaemia after revascularization therapy.
  • 5\. Patients with severe heart failure (NYHA class III and IV)
  • 6\. Patients with neurological or orthopaedic disability, limiting their capability to walk and run

Outcomes

Primary Outcomes

Not specified

Similar Trials